Ethos Technologies Inc (LIFE)
NASDAQFinancialsInsurance - BrokersSnapshot 2026-09-04
$39.85+5.67%
Close 2026-09-04 · 1-day change
NASDAQFinancialsInsurance - BrokersSnapshot 2026-09-04
Warn: Primary pillar under pressure — Improve adjusted EBITDA to $103M-$107M for 2026: FY26 EBITDA guidance $119M-$123M vs ~$105M target.
Ethos aims to reach $563M revenue in 2026. It targets adjusted EBITDA near $105M. The company is addressing recent earnings misses. The stock trades below Street targets, offering potential upside.
Ethos missed earnings recently and faces investor doubts. Profitability remains weak with a net loss in Q1. The stock is under pressure amid a selloff and short reports.
The price is about 14% above our fair value near $17. Our fair value is 37% below the Street median of $27, reflecting skepticism on Ethos's turnaround.
Breaks if: annual revenue falls below $561M in FY26
Continue driving strong revenue growth to meet or exceed full-year 2026 revenue guidance.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story within the Financials sector. The current thesis state is cautious, as recent performance has not met industry standards, but there are signs of potential improvement.
The market appears to be pricing in a fragile situation, given the expensive valuation relative to peers. There is an expectations gap, indicating that the market may not fully account for the company's recent challenges.
Management is focused on achieving revenue and adjusted EBITDA guidance for 2026, with recent results showing progress in these areas. However, there is a moderate risk of missing estimates, which could impact future performance.
The thesis hinges on the performance of sector bellwethers like MRSH, AON, and AJG. If these companies continue to perform well, it could provide a favorable environment for LIFE. Conversely, any negative guidance from these peers could lead to a decline in momentum.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The company reported a strong earnings beat. However, revenue guidance for 2026 raises concerns. Management expects revenue growth but margins are compressing. This could impact future profitability.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. Revenue grew 113% year-over-year to $189.6 million in 2026-Q2 from $88.8 million in 2025-Q2. Full year 2026 revenue guidance increased from $561-$565 million in Q1 to $727-$731 million in Q2, reflecting management's upward revision and delivering strong growth.
“For the full fiscal year 2026, Ethos expects total revenue between $727 million and $731 million.”
“For the full fiscal year 2026, Ethos expects total revenue between $561 million and $565 million.”
Breaks if: earnings continue to miss guidance in next 2 quarters
Ethos is addressing the earnings miss reported in the recent quarter.
Breaks if: adjusted EBITDA falls below $103M in FY26
Ethos aims to improve its adjusted EBITDA to between $103M and $107M for fiscal year 2026.
Over the next 1 to 3 years, LIFE's performance will depend on management's execution and external sector conditions. Not investment advice.